Statistics for Profound Medical Corp (id:13577 PRN)
Valuation metrics
Market cap
278.68M
Enterprise value
360.03M
Trailing P/E (ttm)
-7.81
Forward P/E
-9.83
PEG ratio
-9.83
Price/Sales (ttm)
31.02
Price/Book (mrq)
8.96
Enterprise Value/Revenue
28.50
Enterprise Value/EBITDA
-7.89
Overview
Shares outstanding
24.66M
Float
22.31M
Shares short
76.41K
% Held by insiders
0.09%
% Held by institutions
0.44%
Average volume (10 days)
10.17K
Average volume (90 days)
Price summary
52-Week low
9.55
52-Week high
15.75
52-Week change
-42.08%
Beta
0.83
50-Day moving average
10.69
200-Day moving average
11.47
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
October 16th, 2019
Ex-dividend date
Last split factor
2:1
Last split date
October 16th, 2019
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
60.87%
Operating margin
-317.37%
Operational effectiveness
Return on assets
-44.62%
Return on equity
-90.17%
Income statement
Revenue (ttm)
0.38
Revenue per share (ttm)
0.38
Quarterly revenue growth (yoy)
Gross profit (ttm)
4.38M
EBITDA
-45,634,108.00
Net income to common (ttm)
-44,132,606.00
Diluted EPS (ttm)
-1.87
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
38.13M
Total cash per share (mrq)
1.10
Total debt (mrq)
8.76M
Total Debt/Equity (mrq)
20.05
Current ratio (mrq)
612.30%
Book value per share (mrq)
1.26
Cash flow
Cash flow statement
-34,905,685.00
Levered free cash flow (LFCF)
-20,786,582.00